Literature DB >> 23517795

Protein oxidation in a group of subjects with metabolic syndrome.

Gregorio Caimi1, Eugenia Hopps, Davide Noto, Baldassare Canino, Maria Montana, Daniela Lucido, Rosalia Lo Presti, Maurizio R Averna.   

Abstract

AIMS: To examine the protein oxidation, marker of the oxidative stress, in metabolic syndrome (MS).
METHODS: We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) were with diabetes mellitus and 63 (31 women and 32 men) were without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The protein oxidation, expressed as carbonyl groups, was measured by an enzyme-like immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG, Switzerland).
RESULTS: In the whole group of MS subjects, in comparison with control group, a significant increase in carbonyl groups was present. The same datum was also evident between control group and diabetic subjects with MS and between control group and nondiabetic subjects with MS. No difference was observed between the two subgroups (diabetic and nondiabetic subjects with MS) about NOx. Few information were obtained examining the linear regression among carbonyl groups, age, BMI, waist circumference, blood pressure values and metabolic pattern of MS subjects.
CONCLUSIONS: In MS subject we observed an increase of protein oxidation not influenced by diabetes mellitus. Several strategies may be employed to reduce this parameter.
Copyright © 2013 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23517795     DOI: 10.1016/j.dsx.2013.02.013

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

Review 1.  Biological functions of histidine-dipeptides and metabolic syndrome.

Authors:  Byeng Chun Song; Nam-Seok Joo; Giancarlo Aldini; Kyung-Jin Yeum
Journal:  Nutr Res Pract       Date:  2014-01-29       Impact factor: 1.926

2.  Lipid peroxidation, nitric oxide metabolites, and their ratio in a group of subjects with metabolic syndrome.

Authors:  Gregorio Caimi; Rosalia Lo Presti; Maria Montana; Davide Noto; Baldassare Canino; Maurizio R Averna; Eugenia Hopps
Journal:  Oxid Med Cell Longev       Date:  2014-06-02       Impact factor: 6.543

3.  Study of the correlations among some parameters of the oxidative status, gelatinases, and their inhibitors in a group of subjects with metabolic syndrome.

Authors:  E Hopps; R Lo Presti; M Montana; B Canino; M R Averna; G Caimi
Journal:  Mediators Inflamm       Date:  2014-07-10       Impact factor: 4.711

4.  Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome.

Authors:  E Zurawska-Płaksej; E Grzebyk; D Marciniak; A Szymańska-Chabowska; A Piwowar
Journal:  J Endocrinol Invest       Date:  2014-06-24       Impact factor: 4.256

5.  Identification of Protein Carbonyls (PCOs) in Canine Serum by Western Blot Technique and Preliminary Evaluation of PCO Concentration in Dogs With Systemic Inflammation.

Authors:  Beatrice Ruggerone; Graziano Colombo; Saverio Paltrinieri
Journal:  Front Vet Sci       Date:  2020-12-09

Review 6.  The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.

Authors:  Adam Włodarski; Justyna Strycharz; Adam Wróblewski; Jacek Kasznicki; Józef Drzewoski; Agnieszka Śliwińska
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.